• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antithrombotic therapy in patients with atrial fibrillation undergoing PCI remains a moving target, yet with a clearer direction!

作者信息

Vranckx Pascal, Valgimigli Marco

机构信息

Department of Cardiology and Critical Care Medicine, Hartcentrum Hasselt, Jessa Ziekenhuis, Hasselt, Belgium.

Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium.

出版信息

EuroIntervention. 2022 Jul 22;18(4):e267-e268. doi: 10.4244/EIJ-E-22-00004.

DOI:10.4244/EIJ-E-22-00004
PMID:35866255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9912951/
Abstract
摘要

相似文献

1
Antithrombotic therapy in patients with atrial fibrillation undergoing PCI remains a moving target, yet with a clearer direction!接受经皮冠状动脉介入治疗（PCI）的心房颤动患者的抗栓治疗仍然是一个不断变化的目标，但方向更加明确了！
EuroIntervention. 2022 Jul 22;18(4):e267-e268. doi: 10.4244/EIJ-E-22-00004.
2
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.抗栓治疗在房颤和急性冠脉综合征患者中治疗药物或经皮冠状动脉介入或接受择期经皮冠状动脉介入治疗:从 AUGUSTUS 试验的见解。
Circulation. 2019 Dec 3;140(23):1921-1932. doi: 10.1161/CIRCULATIONAHA.119.043308. Epub 2019 Sep 26.
3
And now we have the AUGUSTUS … How will it impact on antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention?现在我们有了AUGUSTUS研究……它将如何影响接受经皮冠状动脉介入治疗的房颤患者的抗栓治疗？
Eur J Intern Med. 2019 Jul;65:1-3. doi: 10.1016/j.ejim.2019.05.019. Epub 2019 May 23.
4
Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention.接受经皮冠状动脉介入治疗的心房颤动患者的三联、双联和单联抗栓治疗。
Cardiovasc Interv Ther. 2020 Jan;35(1):44-51. doi: 10.1007/s12928-019-00600-1. Epub 2019 Jul 8.
5
Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS.应对心房颤动合并冠状动脉疾病患者抗栓治疗的复杂局面：来自AUGUSTUS研究的经验教训
Eur J Intern Med. 2019 Jul;65:4-5. doi: 10.1016/j.ejim.2019.05.018. Epub 2019 May 23.
6
Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.经皮冠状动脉介入治疗的心房颤动患者的抗血栓治疗。
Cardiol Clin. 2020 Nov;38(4):551-561. doi: 10.1016/j.ccl.2020.07.006. Epub 2020 Sep 17.
7
Meta-analysis of antithrombotic therapy with new oral anticoagulants in patients with atrial fibrillation after percutaneous coronary intervention.经皮冠状动脉介入治疗后房颤患者使用新型口服抗凝药进行抗血栓治疗的荟萃分析
Eur J Prev Cardiol. 2020 Dec;27(19):2119-2122. doi: 10.1177/2047487319865048. Epub 2019 Jul 26.
8
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update.接受经皮冠状动脉介入治疗的心房颤动患者的抗栓治疗：北美视角 - 2016年更新
Circ Cardiovasc Interv. 2016 Nov;9(11). doi: 10.1161/CIRCINTERVENTIONS.116.004395.
9
The Times They Are A-Changin´: Antithrombotic strategies in patients with acute coronary syndrome undergoing coronary stenting who have concomitant atrial fibrillation.时代在变：接受冠状动脉支架置入术且合并心房颤动的急性冠状动脉综合征患者的抗栓策略
Eur J Intern Med. 2021 Jun;88:21-22. doi: 10.1016/j.ejim.2021.04.008. Epub 2021 Apr 30.
10
[Recent advances in antithrombotic therapy for patients with coronary artery disease undergoing percutaneous coronary intervention].[接受经皮冠状动脉介入治疗的冠心病患者抗血栓治疗的最新进展]
Zhonghua Xin Xue Guan Bing Za Zhi. 2021 Feb 24;49(2):108-110. doi: 10.3760/cma.j.cn112148-20201222-01010.

本文引用的文献

1
A novel risk score to identify the need for triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a post hoc analysis of the RE-DUAL PCI trial.一种新的风险评分模型，用于识别行经皮冠状动脉介入治疗的心房颤动患者中三联抗栓治疗的需求：RE-DUAL PCI 试验的事后分析。
EuroIntervention. 2022 Jul 22;18(4):e292-e302. doi: 10.4244/EIJ-D-21-00165.
2
Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial.高出血风险患者经皮冠状动脉介入治疗后双联抗血小板治疗与或不联合口服抗凝治疗:一项开放标签、随机、对照试验。
Circulation. 2021 Oct 12;144(15):1196-1211. doi: 10.1161/CIRCULATIONAHA.121.056680. Epub 2021 Aug 29.
3
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.高出血风险患者经皮冠状动脉介入治疗（PCI）后的双联抗血小板治疗。
N Engl J Med. 2021 Oct 28;385(18):1643-1655. doi: 10.1056/NEJMoa2108749. Epub 2021 Aug 28.
4
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update.接受经皮冠状动脉介入治疗的口服抗凝治疗心房颤动患者的抗栓治疗：北美视角：2021年更新
Circulation. 2021 Feb 9;143(6):583-596. doi: 10.1161/CIRCULATIONAHA.120.050438. Epub 2021 Feb 8.
5
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会（ESC）与欧洲心胸外科学会（EACTS）合作制定的心房颤动诊断和管理指南：欧洲心脏病学会（ESC）心房颤动诊断和管理特别工作组，由ESC欧洲心律协会（EHRA）特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
6
Stent Thrombosis in Patients With Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial.AUGUSTUS试验中接受冠状动脉支架置入术的房颤患者的支架内血栓形成
Circulation. 2020 Mar 3;141(9):781-783. doi: 10.1161/CIRCULATIONAHA.119.044584. Epub 2019 Nov 11.
7
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial.依度沙班与维生素 K 拮抗剂在房颤患者成功经皮冠状动脉介入治疗后抗栓治疗方案的比较（ENTRUST-AF PCI）：一项随机、开放标签、3b 期临床试验。
Lancet. 2019 Oct 12;394(10206):1335-1343. doi: 10.1016/S0140-6736(19)31872-0. Epub 2019 Sep 3.
8
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.心房颤动急性冠状动脉综合征或经皮冠状动脉介入治疗后的抗血栓治疗。
N Engl J Med. 2019 Apr 18;380(16):1509-1524. doi: 10.1056/NEJMoa1817083. Epub 2019 Mar 17.
9
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.房颤患者 PCI 术后的达比加群双重抗血栓治疗。
N Engl J Med. 2017 Oct 19;377(16):1513-1524. doi: 10.1056/NEJMoa1708454. Epub 2017 Aug 27.
10
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.经皮冠状动脉介入治疗（PCI）的房颤患者的出血预防。
N Engl J Med. 2016 Dec 22;375(25):2423-2434. doi: 10.1056/NEJMoa1611594. Epub 2016 Nov 14.